250+
mock exams
46,658
tests completed
7,67,650
questions answered
This article discusses the concept of **gene drives**, a genetic engineering technique designed to bias inheritance in favor of a specific trait, spreading it rapidly through a population. It highlights the potential of gene drives to eliminate disease vectors like mosquitoes while raising significant concerns about the unpredictable evolutionary trade-offs and ecological consequences of human intervention in natural systems.
A gene drive is a type of genetic engineering that creates a biased inheritance, bypassing normal Mendelian genetics. Typically, offspring have a 50% chance of inheriting a gene from either parent. However, gene drives use mechanisms like CRISPR-Cas9 to ensure a specific gene is passed on to nearly all offspring, spreading rapidly through a population. The article explains how this could be used to target vectors of diseases like malaria or dengue, either by making mosquitoes sterile (causing population collapse) or by making them resistant to the parasite (reducing disease burden). UPSC candidates must understand the distinction between normal genetic modification (which can be diluted over generations) and gene drives (which amplify and persist). Questions in GS-3 may test the mechanism of gene drives, the role of CRISPR-Cas9 in facilitating them, and the ethical/ecological implications of synthetic biology.
The ecological implications of releasing gene drives into the wild are profound and complex. The article points out that while natural "selfish genes" (like transposable elements or viruses) exist, they are constrained by natural selection and host resistance, leading to an evolutionary balance. Human-engineered gene drives, however, attempt to impose our pace and goals on natural ecosystems. Releasing genetically altered organisms could lead to unintended consequences, such as the disruption of food webs (if a mosquito population collapses) or the horizontal transfer of the engineered gene to non-target species. Furthermore, nature often develops resistance to such interventions, potentially rendering the gene drive ineffective over time. The Convention on Biological Diversity (CBD) and its Cartagena Protocol on Biosafety are relevant international frameworks governing the safe handling, transport, and use of Living Modified Organisms (LMOs). The Genetic Engineering Appraisal Committee (GEAC) under the Ministry of Environment, Forest and Climate Change regulates such activities in India.
The potential public health benefits of gene drives are immense, particularly for vector-borne diseases that disproportionately affect developing nations. By altering mosquito populations, gene drives offer a novel approach to disease eradication that could supplement or even replace traditional methods like insecticides (which face issues of resistance and environmental toxicity) or vaccines. The article outlines two primary strategies: population suppression (making males sterile) and population replacement (making vectors incapable of transmitting the pathogen). In the context of India's fight against malaria, dengue, and chikungunya, such technologies could be game-changers. However, this must be balanced against the risks of creating "super-vectors" or unpredictable biological outcomes. The debate around gene drives touches upon the concept of One Health, which emphasizes the interconnectedness of human, animal, and environmental health, a critical theme for GS-3.